# BEIZRAY

NDC: 83513-009
Generic name: Docetaxel
Labeler / Manufacturer: Zhuhai Beihai Biotech Co., Ltd.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20241023

FDA application: NDA218711

## Active ingredients

- DOCETAXEL ANHYDROUS: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83513-009"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83513-009
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3538b979-8cac-49ed-b8dc-50f73ce38c72